Molecular Imaging for Estrogen Receptor-Positive Breast Cancer: Clinical Applications of Whole Body and Dedicated Breast Positron Emission Tomography.

ABSTRACT: ¹⁸F-fluoroestradiol (¹⁸F-FES) is a Food and Drug Administration-approved radiopharmaceutical used for molecular imaging of the estrogen receptor (ER). When combined with PET, ¹⁸F-FES may improve the diagnosis of ER-positive breast cancer in the metastatic setting and provide insights into tumor heterogeneity. In this article, we review data on the use of ¹⁸F-FES imaging for treatment selection, staging, imaging lobular breast cancer, and the novel breast specific imaging tool, dedicated breast PET.

SUBMITTER: Goodman K 

PROVIDER: S-EPMC10277169 | biostudies-literature | 2022 Oct

REPOSITORIES: biostudies-literature